Advertisement
Screener

FORTREA HOLDINGS INC. (FTRE) Share-based Payment Arrangement, Expense, Tax Benefit

FORTREA HOLDINGS INC. Share-based Payment Arrangement, Expense, Tax Benefit

FORTREA HOLDINGS INC. (FTRE) reported Share-based Payment Arrangement, Expense, Tax Benefit of $2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Expense Statement › Income Tax

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-07-29

  • FORTREA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2026-06-30 was $2.00M, a 35.48% decline year-over-year.
  • FORTREA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $1.90M, a 17.39% decline year-over-year.
  • FORTREA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $2.50M, a 7.41% decline year-over-year.
  • FORTREA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $3.10M, a 47.62% increase year-over-year.
  • FORTREA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $11.00M, a 20.88% increase from fiscal 2024.
  • FORTREA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $9.10M, a 28.17% increase from fiscal 2023.
  • FORTREA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $7.10M, a 24.56% increase from fiscal 2022.
  • FORTREA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $5.70M, a 12.31% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Expense, Tax Benefit 3 monthShare-based Payment Arrangement, Expense, Tax Benefit 3 month as first filedShare-based Payment Arrangement, Expense, Tax Benefit 6 monthShare-based Payment Arrangement, Expense, Tax Benefit 9 monthShare-based Payment Arrangement, Expense, Tax Benefit 9 month as first filedShare-based Payment Arrangement, Expense, Tax Benefit 12 monthShare-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed
2026-06-30$2.00M
10-Q · filed 2026-07-29
$3.90M
10-Q · filed 2026-07-29
$6.40M
derived: sum of 3 quarters · filed 2026-07-29
$9.50M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$1.90M
10-Q · filed 2026-05-05
$4.40M
derived: sum of 2 quarters · filed 2026-05-05
$7.50M
derived: sum of 3 quarters · filed 2026-05-05
$10.60M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$5.60M
derived: sum of 2 quarters · filed 2026-02-26
$8.70M
derived: sum of 3 quarters · filed 2026-07-29
$11.00M
10-K · filed 2026-02-26
2025-09-30$3.10M
10-Q · filed 2025-11-05
$6.20M
derived: sum of 2 quarters · filed 2026-07-29
$8.50M
10-Q · filed 2025-11-05
$11.20M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$3.10M
10-Q · filed 2026-07-29
$5.40M
10-Q · filed 2026-07-29
$8.10M
derived: sum of 3 quarters · filed 2026-07-29
$10.20M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$2.30M
10-Q · filed 2026-05-05
$5.00M
derived: sum of 2 quarters · filed 2026-05-05
$7.10M
derived: sum of 3 quarters · filed 2026-05-05
$9.40M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$2.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$4.80M
derived: sum of 2 quarters · filed 2026-02-26
$7.10M
derived: sum of 3 quarters · filed 2026-02-26
$9.10M
10-K · filed 2026-02-26
2024-09-30$2.10M
10-Q · filed 2025-11-05
$4.40M
derived: sum of 2 quarters · filed 2025-11-05
$6.40M
10-Q · filed 2025-11-05
$9.10M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$2.30M
10-Q · filed 2025-08-06
$4.30M
10-Q · filed 2025-08-06
$7.00M
derived: sum of 3 quarters · filed 2026-02-26
$8.70M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$2.00M
10-Q · filed 2025-05-12
$4.70M
derived: sum of 2 quarters · filed 2026-02-26
$6.40M
derived: sum of 3 quarters · filed 2026-02-26
$8.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$2.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$4.40M
derived: sum of 2 quarters · filed 2026-02-26
$6.00M
derived: sum of 3 quarters · filed 2026-02-26
$7.10M
10-K · filed 2026-02-26
$7.80M
10-K · filed 2024-03-13
2023-09-30$1.70M
10-Q · filed 2024-11-08
$200.00K
10-Q · filed 2023-11-13
$3.30M
derived: sum of 2 quarters · filed 2024-11-08
$4.40M
10-Q · filed 2024-11-08
$1.70M
10-Q · filed 2023-11-13
2023-06-30$1.60M
10-Q · filed 2024-08-12
$2.70M
10-Q · filed 2024-08-12
2023-03-31$1.10M
10-Q · filed 2024-05-24
2022-12-31$5.70M
10-K · filed 2025-03-03
$9.70M
10-K · filed 2024-03-13
2021-12-31$6.50M
10-K · filed 2024-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CareDx, Inc. (CDNA)United States$3.174B13.21
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64